Lineage Cell Therapeutics (LCTX) Divestments (2018)

Lineage Cell Therapeutics' Divestments history runs 1 years deep, the most recent figure standing at $3.2 million for Q1 2018.

• In Q1 2018, Divestments changed N/A year-over-year to $3.2 million; the TTM figure through Dec 2018 stood at $3.2 million (changed N/A YoY), while the FY2018 annual figure was $3.2 million, changed N/A from the prior year.
• Divestments for Q1 2018 stood at $3.2 million.
• The five-year high for Divestments was $3.2 million in Q1 2018, with the low at $3.2 million in Q1 2018.